Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pathology
Volume 2011 (2011), Article ID 514613, 4 pages
http://dx.doi.org/10.1155/2011/514613
Case Report

Acute Demyelination in a Person with Amphetamine Abuse

1Laboratory of Neuropathology, Department of Pathology and Neuropathology, State Neuropsychiatric Hospital Wagner-Jauregg, Wagner-Jauregg-Weg 15, 4020 Linz, Austria
2Institute of Legal Medicine, University of Rostock, 18055 Rostock, Germany

Received 20 June 2011; Accepted 16 August 2011

Academic Editor: P. Tosi

Copyright © 2011 Serge Weis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Karch, Karch's Pathology of Drug Abuse, CRC Press, Boca Raton, Fla, USA, 3rd edition, 2002.
  2. P. Delaney and M. Estes, “Intracranial hemorrhage with amphetamine abuse,” Neurology, vol. 30, no. 10, pp. 1125–1128, 1980. View at Google Scholar · View at Scopus
  3. K. Suzuki, “Demyelinating disorders and leukodystrophies,” in Neuropathology. The Diagnostic Approach, J. H. Garcia, Ed., pp. 669–715, Mosby, St. Louis, Mo, USA, 1997. View at Google Scholar
  4. R. T. Johnson and E. O. Major, “Infectious demyelinating diseases,” in Myelin Biology and Disorders, R. A. Lazzarini, Ed., pp. 953–983, Academic Press, New York, NY, USA, 2004. View at Google Scholar
  5. P. K. Stys and S. G. Waxman, “Ischemic white matter damage,” in Myelin Biology and Disorders, R. A. Lazzarini, Ed., pp. 985–1007, Academic Press, New York, NY, USA, 2004. View at Google Scholar
  6. M. L. Cuzner and W. T. Norton, “Biochemistry of demyelination,” Brain Pathology, vol. 6, no. 3, pp. 231–242, 1996. View at Google Scholar · View at Scopus
  7. J. H. Noseworthy, “Progress in determining the causes and treatment of multiple sclerosis,” Nature, vol. 399, pp. A40–A47, 1999. View at Google Scholar · View at Scopus
  8. D. Schiffer, F. Brignolio, M. T. Giordana, T. Mongini, A. Migheli, and L. Palmucci, “Spongiform encephalopathy in addicts inhaling pre-heated heroin,” Clinical Neuropathology, vol. 4, pp. 174–180, 1985. View at Google Scholar
  9. E. C. Wolters, F. C. Stam, and R. J. Lousberg, “Leucoencephalopathy after inhaling “heroin“ pyrolysate,” The Lancet, vol. 2, no. 8310, pp. 1233–1237, 1982. View at Google Scholar · View at Scopus
  10. E. A. De Letter, M. F. A. Espeel, M. E. C. Craeymeersch et al., “Immunohistochemical demonstration of the amphetamine derivatives 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) in human post-mortem brain tissue and the pituitary gland,” International Journal of Legal Medicine, vol. 117, no. 1, pp. 2–9, 2003. View at Google Scholar · View at Scopus
  11. B. P. Sokolov, O. O. Polesskaya, and G. R. Uhl, “Mouse brain gene expression changes after acute and chronic amphetamine,” Journal of Neurochemistry, vol. 84, no. 2, pp. 244–252, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. D. N. Albertson, B. Pruetz, C. J. Schmidt, D. M. Kuhn, G. Kapatos, and M. J. Bannon, “Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin,” Journal of Neurochemistry, vol. 88, no. 5, pp. 1211–1219, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. M. J. Núñez, J. Balboa, M. Rey-Méndez et al., “Effects of amphetamine and cocaine on the development of acute experimental allergic encephalomyelitis in Lewis rats,” Human and Experimental Toxicology, vol. 26, no. 8, pp. 637–643, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. R. H. B. Benedict, F. Munschauer, P. Zarevics et al., “Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients,” Journal of Neurology, vol. 255, no. 6, pp. 848–852, 2008. View at Publisher · View at Google Scholar · View at PubMed